| Literature DB >> 35965609 |
Sol Vidal-Almela1, Tasuku Terada1, Christie A Cole1, Carley D O'Neill1, Katelyn Comeau1, Isabela R Marçal1, Andrew L Pipe1, Jennifer L Reed1.
Abstract
Background: Atrial fibrillation (AF) is a serious medical condition and a burgeoning patient population. Chronic exercise training, including high-intensity interval training (HIIT), has been shown to improve symptoms and quality of life in patients with AF. Yet, the acute responses to HIIT in this population remain understudied, leaving clinicians and patients hesitant about prescribing and engaging in high-intensity exercise, respectively. Case summary: This case series describes acute exercise responses [i.e. power output, heart rate (HR), blood pressure (BP), ratings of perceived exertion (RPE), symptoms] to 10 weeks (3 days/week) of HIIT. Participants were four white males (58-80 years old) with permanent AF, co-morbidities (diabetes, coronary artery disease, Parkinson's disease), and physical limitations. The increases in HR and BP during HIIT were modest across all participants, regardless of age and medication use. Differences in RPE were observed; the oldest participant perceived the sessions as more challenging despite a lower HR response. All patients complied with the HIIT prescription of 80-100% of peak power output by week 4. No adverse events were reported. Discussion: Patients' concerns regarding high-intensity exercise may discourage them from participating in HIIT, our results demonstrated no abnormal HR or BP (e.g. hypotension) responses during HIIT or cool-down. These findings align with the typical exercise responses noted in other cardiovascular populations. Notwithstanding the high metabolic demands of HIIT, male patients with permanent AF tolerated HIIT without problem. Further investigation of HIIT as an approach to enable those with AF to recover physical capacity and minimize symptomatology is warranted.Entities:
Keywords: Acute exercise; Atrial fibrillation; Case report; Exercise training; HIIT; High-intensity interval training; Physical activity
Year: 2022 PMID: 35965609 PMCID: PMC9366644 DOI: 10.1093/ehjcr/ytac320
Source DB: PubMed Journal: Eur Heart J Case Rep ISSN: 2514-2119
Characteristics of four white male patients with permanent atrial fibrillation
| Case 1 | Case 2 | Case 3 | Case 4 | |
|---|---|---|---|---|
| Age (years) | 58 | 67 | 74 | 80 |
| Height (cm) | 168.9 | 176.1 | 180.2 | 172.5 |
| Body mass (kg) | 95.4 | 71.9 | 110.0 | 86.9 |
| BMI (kg/m2) | 33.4 | 23.2 | 33.9 | 29.2 |
| Waist circumference (cm) | 112.0 | 86.5 | 119.5 | 102.5 |
| Resting systolic BP (mmHg) | 98 | 120 | 142 | 126 |
| Resting diastolic BP (mmHg) | 70 | 70 | 80 | 70 |
| Resting heart rate (b.p.m.) | 109 | 91 | 81 | 73 |
| V̇O2peak (mL/kg/min) | 22.5 | 25.7 | 14.5 | 15.7 |
| Peak power output (W) | 193 | 180 | 156 | 140 |
| Prescription for high-intensity bouts (W) | 154–193 | 144–180 | 123–156 | 112–140 |
|
| ||||
| Overall | 98 | 73 | 73 | 88 |
| Symptoms | 100 | 88 | 75 | 92 |
| Daily activities | 96 | 83 | 67 | 83 |
| Treatment concern | 100 | 72 | 83 | 97 |
| Treatment satisfaction | 100 | 0 | 58 | 67 |
|
| ||||
| Dyslipidaemia | Low back pain | Dyslipidaemia | Low back pain | |
|
| ||||
| — | Four ablations | — | PCI | |
|
| ||||
| Anti-coagulant | — | Rivaroxaban | Rivaroxaban | Warfarin |
| Anti-platelet | Aspirin | — | — | — |
| Anti-hypertensive | — | — | Ramipril | — |
| Anti-dyslipidaemic | Atorvastatin | — | Rosuvastatin | — |
| β-Blocker | — | — | Bisoprolol | — |
| Other | Tiotropium bromide and zenhale (asthma) | Alendronic acid | Metformin and glicazide (diabetes) | Levocarb (Parkinson) |
AFEQT, Atrial Fibrillation Effect on QualiTy of life—lower scores denote more disability; BMI, body mass index; BP, blood pressure; CAD, coronary artery disease; PCI, percutaneous coronary intervention; , peak aerobic power.